Adaptive Optics Instrumentation for Advanced Ophthalmic Imaging

用于高级眼科成像的自适应光学仪器

基本信息

  • 批准号:
    7690888
  • 负责人:
  • 金额:
    $ 101.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-03-01 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This Bioengineering Research Partnership is a consortium of 6 laboratories that are building adaptive optics scanning laser ophthalmoscopes (AOSLOs) and applying them to microscopic examination of the living normal and diseased retina. The principal investigator is David Williams (University of Rochester) who introduced the first successful adaptive optics instruments to vision science. Other lead investigators include: Steve Burns (Indiana University) an international leader in laser scanning ophthalmoscopy, John Flannery (UC, Berkeley) an expert in retinal degeneration and the development of retinal biomarkers, and Austin Roorda (UC, Berkeley) who designed the first adaptive optics scanning laser ophthalmoscopes, David Arathorn (Montana State University) who brings strong mathematical skills and software development tools for tracking the eye in AOSLOs, and R. Daniel Ferguson (Physical Sciences, Inc.) whose expertise is in the optical engineering of innovative eye tracking systems. During years 1-5 of the previous funding period, the partnership designed and built four AOSLO instruments and two more instruments are under construction. These devices have produced the first images ever of numerous microscopic structures in the living eye including the RPE cell mosaic, single leucocytes flowing in the smallest retinal capillaries, and fluorescently-labelled ganglion cell dendrites, axons and cell bodies. In addition, technical challenges for imaging eyes ranging in size from human to rodent have been overcome. The partnership is now proposing continued funding for years 6-10 to develop new capabilities for these instruments such as a combined hardware and software approach to reduce the effects of eye motion on high resolution retinal imagery. We also will develop a new generation of instruments with special capabilities, such as the ability to image ganglion cells in the living human eye without the use of fluorescent dyes, and the ability to optically record neural responses from specific retinal cells. PUBLIC HEALTH RELEVANCE: This application will develop a technology, adaptive optics scanning laser ophthalmoscopy, for taking extremely sharp pictures of the inside of the living eye, so sharp that individual cells can be seen. This technology will be used to study diseases such as age-related macular degeneration and glaucoma. It may allow the earlier detection of retinal disease, better tracking of disease progression, and the efficacy of therapies for retinal disease.
描述(由申请人提供):该生物工程研究伙伴关系是由6个实验室组成的联盟,这些实验室正在构建自适应光学扫描激光检眼镜(AOSLO),并将其应用于活体正常和患病视网膜的显微镜检查。主要研究者是大卫威廉姆斯(罗切斯特大学),他将第一个成功的自适应光学仪器引入视觉科学。其他主要研究者包括:Steve Burns(印第安纳州大学)是激光扫描检眼镜的国际领导者,John Flannery(加州大学伯克利分校)是视网膜变性和视网膜生物标志物开发方面的专家,Austin Roorda(加州大学伯克利分校)设计了第一台自适应光学扫描激光检眼镜,大卫Arathorn(蒙大拿州立大学)带来了强大的数学技能和软件开发工具,用于在AOSLO中跟踪眼睛,R.丹尼尔弗格森(物理科学公司)他的专长是创新眼动追踪系统的光学工程。在上一个资助期的第1-5年,该伙伴关系设计和建造了四台AOSLO仪器,另有两台仪器正在建造中。这些设备已经产生了有史以来第一个图像的许多微观结构在活的眼睛,包括视网膜色素上皮细胞马赛克,单个白细胞流动的最小的视网膜毛细血管,和荧光标记的神经节细胞树突,轴突和细胞体。此外,从人类到啮齿动物大小不等的眼睛成像的技术挑战也已被克服。该合作伙伴关系现在提议在6-10年内继续提供资金,以开发这些仪器的新功能,例如硬件和软件相结合的方法,以减少眼睛运动对高分辨率视网膜图像的影响。我们还将开发具有特殊功能的新一代仪器,例如能够在不使用荧光染料的情况下对活体人眼中的神经节细胞进行成像,以及能够光学记录特定视网膜细胞的神经反应。公共卫生相关性:这项应用将开发一种技术,自适应光学扫描激光检眼镜,用于拍摄活体眼睛内部的极其清晰的照片,清晰到可以看到单个细胞。这项技术将用于研究老年性黄斑变性和青光眼等疾病。它可以更早地检测视网膜疾病,更好地跟踪疾病进展以及视网膜疾病治疗的疗效。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID R WILLIAMS其他文献

DAVID R WILLIAMS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID R WILLIAMS', 18)}}的其他基金

High Resolution Mapping of Foveal Ganglion Cell Receptive Fields in the Living Primate Eye
活体灵长类动物眼睛中心凹神经节细胞感受野的高分辨率绘图
  • 批准号:
    10319191
  • 财政年份:
    2021
  • 资助金额:
    $ 101.95万
  • 项目类别:
High Resolution Mapping of Foveal Ganglion Cell Receptive Fields in the Living Primate Eye
活体灵长类动物眼睛中心凹神经节细胞感受野的高分辨率绘图
  • 批准号:
    10534734
  • 财政年份:
    2021
  • 资助金额:
    $ 101.95万
  • 项目类别:
Accelerating vision restoration with in-vivo cellular imaging of retinal function
通过视网膜功能的体内细胞成像加速视力恢复
  • 批准号:
    9292320
  • 财政年份:
    2015
  • 资助金额:
    $ 101.95万
  • 项目类别:
Accelerating vision restoration with in-vivo cellular imaging of retinal function
通过视网膜功能的体内细胞成像加速视力恢复
  • 批准号:
    9059096
  • 财政年份:
    2015
  • 资助金额:
    $ 101.95万
  • 项目类别:
Accelerating vision restoration with in-vivo cellular imaging of retinal function
通过视网膜功能的体内细胞成像加速视力恢复
  • 批准号:
    8912743
  • 财政年份:
    2015
  • 资助金额:
    $ 101.95万
  • 项目类别:
CVS SYMPOSIUM: PHOTONS AND NEURONS
CVS 研讨会:光子和神经元
  • 批准号:
    7913567
  • 财政年份:
    2010
  • 资助金额:
    $ 101.95万
  • 项目类别:
CORE-ADMINISTRATIVE
核心行政
  • 批准号:
    7690024
  • 财政年份:
    2008
  • 资助金额:
    $ 101.95万
  • 项目类别:
Optics Instrumentation for Advanced Ophthalmic Imaging
用于高级眼科成像的光学仪器
  • 批准号:
    7194997
  • 财政年份:
    2003
  • 资助金额:
    $ 101.95万
  • 项目类别:
Adaptive Optics Instrumentation for Advanced Ophthalmic Imaging
用于高级眼科成像的自适应光学仪器
  • 批准号:
    7931934
  • 财政年份:
    2003
  • 资助金额:
    $ 101.95万
  • 项目类别:
Optics Instrumentation for Advanced Ophthalmic Imaging
用于高级眼科成像的光学仪器
  • 批准号:
    7037410
  • 财政年份:
    2003
  • 资助金额:
    $ 101.95万
  • 项目类别:

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    $ 101.95万
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    $ 101.95万
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    $ 101.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 101.95万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 101.95万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 101.95万
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    $ 101.95万
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    $ 101.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 101.95万
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    $ 101.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了